Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions

Clinical trial NCT02359045 · COMPLETED

Trial details

NCT number: NCT02359045
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relative Bioavailability AUC Cmax Pharmacokinetics

Start date: 2015-02-12
Primary completion: 2015-07-27
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.